G. Morini et al., Synthesis of 1,2-benzisothiazole derivatives and investigation of their putative histaminergic activity, FARMACO, 54(11-12), 1999, pp. 740-746
Some new 2-(1,2-benzisothiazol-3-yl)ethylamine derivatives were synthesised
and their putative histaminergic activity was investigated in in vitro gas
trointestinal and cardiac preparations. In the isolated guinea pig duodenum
, all the compounds induced a tetrodotoxin- and atropine-sensitive contract
ile activity, which was minimally affected by mepyramine in the case of the
compound 2-(1,2-benzisothiazol-3-yl)ethylamine. In the same tissue, all th
e compounds were devoid of any H-3 receptor agonistic or antagonistic activ
ity, but caused a nicotinic and/or 5-HT3 receptor activation. None of these
compounds induced any histamine H-2 agonistic or antagonistic activity in
the isolated guinea pig gastric mucose or in the isolated papillary muscle.
On this latter substrate, the compound N,N,N-trimethyl-2-(1,2-benzisothiaz
ol-3-yl)ethylammonium iodide induced a positive inotropic activity, apparen
tly due to a release of catecholamines. These results demonstrate the subst
antial inability of 1,2-benzisothiazole derivatives to interact with histam
ine receptors in functional tests. These compounds, however, possess gangli
omimetic properties, related to the activation of 5HT(3) and/or nicotinic r
eceptors, (C) 1999 Elsevier Science S.A. All rights reserved.